Pharmagenome (PGT)

A Blockchain Based Crowdsourced Platform

Review Score
ICO Price
Pre ICO Price
Soft Cap
Hard Cap
90,000 USD
Start Date
25 May 2018
End Date
8 June 2018

What is Pharmagenome?


A Blockchain based crowdsourced platform for investment and development of an information platform that will alert people to their genetic diseases, guides them with preventive behaviors regarding the way of life and nutrition according to their genetic predispositions in order to escape serious illnesses and help patients select the effective drug and the optimum dose of the drug with respect to their genome. The project is based on Waves platform providing utilities that classical approaches do not utilize to the potential investors.

The platform will enable: Genome analysis; Secure storage of full genome information with blockchain technology; Complete database of polymorphisms; Full interpretation with our medical team; Analysis of cancer cells genome.

Our advantage is the high level of professionalism of the project team and the extremely rapidly developing areas of the pharma genetics, which has recently received extraordinary growth in all areas of medicine. The project PHARMAGENOME is a touch point with investors rapidly growing market of using human genome for mere effective medical treatment of patients.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.